Palatin Technologies, Inc. , a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor (MCR) system, today announced ...

Advancing differentiated MC4R-based obesity programs into clinical development Melanocortin-based obesity therapies targeting rare MC4R pathway disorders with a primary ...

Regulated information Challenging 2025, with results in line with latest outlook, but significantly lower than initial expectations; Clear priorities set for 2026 to resume profit growth and improve ...

British/Irish people call big government projects like this “schemes,” possibly due to a lack of cultural familiarity with ...

Starbucks benefits from Brian Niccol's tactical marketing expertise, driving brand visibility and operational tweaks. Read my ...

Sandisk (SNDK) rated Sell: peak margins from tight NAND supply may fade; limited volume upside and high ASP risk.

Birchcliff Energy Ltd. (“Birchcliff” or the “Corporation”) (TSX: BIR) is pleased to announce its unaudited 2025 full-year and fourth quarter financial and ...

Birchcliff added an aggregate of 30.1 MMboe of PDP reserves on an F&D basis in 2025, after adding back 2025 actual production of 29.2 MMboe. (7) Birchcliff’s PDP reserves totalled 218.0 MMboe at ...

Discover baby bonds, an affordable fixed-income security for retail, or individual, investors, under $1,000. Learn how they work, their benefits, and alternatives.